BBS1 and Alzheimer disease: In conclusion, the administration of mAb BBS1 to 3xTg-AD mice not only improves the cognitive function of the mice, but also lowers the levels of total Aβ, total tau and phosphorylated tau, and moderates the inflammatory response.